Furthermore, a specific noncompetitive inhibitor for NAMPT, FK866, showed significant induction of delayed cell death in human HepG2 cells, indicating a potentially novel approach for triggering apoptosis in cancer cells [51]. Here, NAMPT is linked to cancer.